XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 67 filers reported holding XENON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,216,984 | +147.7% | 64,900 | +185.9% | 0.01% | +200.0% |
Q4 2022 | $895,061 | -72.8% | 22,700 | -75.1% | 0.00% | -80.0% |
Q3 2022 | $3,285,000 | +106.5% | 91,000 | +74.0% | 0.01% | +100.0% |
Q2 2022 | $1,591,000 | -57.6% | 52,300 | -57.4% | 0.01% | -50.0% |
Q1 2022 | $3,751,000 | -5.2% | 122,700 | -3.1% | 0.01% | 0.0% |
Q4 2021 | $3,955,000 | +47.2% | 126,600 | -28.0% | 0.01% | +42.9% |
Q3 2021 | $2,686,000 | +73.9% | 175,800 | +111.8% | 0.01% | +75.0% |
Q2 2021 | $1,545,000 | -2.9% | 83,000 | -6.6% | 0.00% | 0.0% |
Q1 2021 | $1,591,000 | +5.0% | 88,900 | -9.7% | 0.00% | 0.0% |
Q4 2020 | $1,515,000 | +29.5% | 98,500 | -6.8% | 0.00% | +33.3% |
Q3 2020 | $1,170,000 | -7.5% | 105,700 | +4.8% | 0.00% | -25.0% |
Q2 2020 | $1,265,000 | +75.7% | 100,900 | +58.9% | 0.00% | +33.3% |
Q1 2020 | $720,000 | +65.9% | 63,500 | +91.8% | 0.00% | +200.0% |
Q4 2019 | $434,000 | +79.3% | 33,100 | +23.0% | 0.00% | 0.0% |
Q3 2019 | $242,000 | -24.6% | 26,900 | -17.5% | 0.00% | 0.0% |
Q2 2019 | $321,000 | -14.9% | 32,600 | -12.1% | 0.00% | 0.0% |
Q1 2019 | $377,000 | +65.4% | 37,100 | +2.5% | 0.00% | 0.0% |
Q4 2018 | $228,000 | – | 36,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |